X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (90) 90
hematology (83) 83
transplantation (79) 79
middle aged (68) 68
index medicus (65) 65
adult (64) 64
male (63) 63
female (62) 62
aged (51) 51
article (50) 50
immunology (49) 49
hematology, oncology and palliative medicine (44) 44
treatment outcome (41) 41
hematopoietic stem cells (38) 38
transplantation, autologous (34) 34
chemotherapy (33) 33
hematopoietic stem cell transplantation - methods (33) 33
hematopoietic stem cell transplantation (32) 32
adolescent (31) 31
analysis (31) 31
disease-free survival (30) 30
oncology (30) 30
survival (26) 26
transplantation conditioning - methods (25) 25
recurrence (23) 23
survival analysis (23) 23
young adult (23) 23
retrospective studies (22) 22
bone-marrow-transplantation (21) 21
hemic and lymphatic diseases (20) 20
bone marrow (19) 19
cancer (19) 19
transplantation, homologous (19) 19
multiple myeloma - therapy (18) 18
stem cells (18) 18
therapy (18) 18
blood (17) 17
clinical medicine (17) 17
klinisk medicin (17) 17
medical and health sciences (17) 17
medicin och hälsovetenskap (17) 17
disease progression (16) 16
hematologi (16) 16
lymphomas (16) 16
multiple myeloma (16) 16
stem-cell transplantation (16) 16
allogeneic transplantation (15) 15
survival rate (15) 15
mortality (14) 14
non-hodgkins-lymphoma (14) 14
autologous transplantation (13) 13
child (13) 13
high-dose chemotherapy (13) 13
leukemia (13) 13
outcomes (13) 13
prognosis (13) 13
hematopoietic stem cell transplantation - adverse effects (12) 12
non-hodgkin lymphoma (12) 12
allogeneic (11) 11
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
care and treatment (11) 11
cohort studies (11) 11
hematopoietic stem cell transplantation - mortality (11) 11
lymphoma, non-hodgkin - therapy (11) 11
multivariate analysis (11) 11
proportional hazards models (11) 11
relapse (11) 11
child, preschool (10) 10
follow-up studies (10) 10
high-dose therapy (10) 10
immune system diseases (10) 10
risk (10) 10
risk factors (10) 10
autografts (9) 9
lymphoma (9) 9
multiple myeloma - mortality (9) 9
patient outcomes (9) 9
rituximab (9) 9
health care sciences & services (8) 8
hematopoietic cell transplantation (8) 8
medical colleges (8) 8
prospective studies (8) 8
reduced-intensity (8) 8
rehabilitation (8) 8
research (8) 8
transplants & implants (8) 8
age factors (7) 7
combined modality therapy (7) 7
european group (7) 7
follow-up (7) 7
impact (7) 7
kaplan-meier estimate (7) 7
lymphoma - therapy (7) 7
medical research (7) 7
multiple-myeloma (7) 7
myeloma (7) 7
registries (7) 7
remission induction (7) 7
adults (6) 6
autologous hematopoietic stem cell transplantation (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 02/2014, Volume 32, Issue 4, pp. 273 - +
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2015, Volume 33, Issue 32, pp. 3741 - 3749
Journal Article
American Journal of Hematology, ISSN 0361-8609, 03/2016, Volume 91, Issue 3, pp. 322 - 329
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2014, Volume 20, Issue 11, pp. 1729 - 1736
Abstract The poor prognosis for patients with diffuse large B cell lymphoma (DLBCL) who relapse within 1 year of initial diagnosis after first-line... 
Hematology, Oncology and Palliative Medicine | Non-Hodgkin lymphoma | Early failure | Autologous transplantation | High-dose therapy | Rituximab | Aggressive lymphoma | Diffuse large B cell lymphoma | INTERMEDIATE-GRADE | CONDITIONING REGIMENS | TRIAL MINT GROUP | CHEMOTHERAPY PLUS RITUXIMAB | GERMINAL-CENTER | Diffuse large Bcell lymphoma | CHOP-LIKE CHEMOTHERAPY | BONE-MARROW TRANSPLANTATION | Diffuse large B cell lymphoma | NON-HODGKINS-LYMPHOMA | SALVAGE THERAPY | IMMUNOLOGY | TRANSPLANTATION | HEMATOLOGY | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prognosis | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Male | Transplantation, Autologous | Treatment Outcome | Disease Progression | Young Adult | Disease-Free Survival | Lymphoma, Large B-Cell, Diffuse - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Treatment Failure | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Transplantation Conditioning - adverse effects | Aged | Hematopoietic Stem Cell Transplantation - methods | Transplantation Conditioning - methods | Cohort Studies | Chemotherapy | Analysis | Immunotherapy | Lymphomas | Transplantation | Hematopoietic stem cells | Cancer | Basic Medicine | Medical and Health Sciences | Hematology | Medicin och hälsovetenskap | Immunologi inom det medicinska området | Klinisk medicin | Clinical Medicine | Hematologi | Medicinska och farmaceutiska grundvetenskaper | Immunology in the medical area
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 12, pp. 2091 - 2099
Journal Article
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 2, pp. 335 - 341
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2014, Volume 20, Issue 11, pp. 1796 - 1803
Journal Article
Bone Marrow Transplantation, ISSN 0268-3369, 11/2015, Volume 50, Issue 11, pp. 1416 - 1423
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2008, Volume 14, Issue 2, pp. 236 - 245
Journal Article